A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms
Clinical trial NCT03075826 · COMPLETED
Trial details
- NCT number
- NCT03075826
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2021-03-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.